Public Citizen vs. PhRMA

hepatitis-cWe square off with PhRMA, the trade group for the multinational NYT logopharmaceutical giants, in letters to The New York Times this week. At stake is treatment rationing, particularly for Hepatitis C. Will those who need treatment receive it?

Comments are closed.